Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.08.30
ag真人平台官方：2022年半年度报告
2022.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
2022.08.15
DATE OF BOARD MEETING
2022.07.21
ag真人平台官方：第五届董事会第二十次会议决议公告
2022.07.21
ag真人平台官方：2021年年度权益分派实施公告
2022.07.13
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE I...
2022.07.13
ag真人平台官方：2022年半年度业绩预告
2022.06.14
ag真人平台官方：ag真人平台官方2021年年度股东大会法律意见书
2022.06.14
ag真人平台官方：2021年年度股东大会决议公告
2022.06.14
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING
第一页
上一页
26
27
28
29
30
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
